NG-01

N/A

Report date: 2025/05/13 10:29:08

Base Information

Drug NameNG-01

Drug Alias NameAutologous bone marrow derived human stromal cells therapy (NeuroGenesis)NG-01

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Somatic cell > Stromal cell therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNeuroGenesis Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesNeuroGenesis Bio Inc

Inactive CompaniesN/A

Active IndicationsMultiple Sclerosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A